-
Je něco špatně v tomto záznamu ?
Synthesis and Characterization of New 3-(4-Arylpiperazin-1-yl)-2-hydroxypropyl 4-Propoxybenzoates and Their Hydrochloride Salts
P. Marvanova, T. Padrtova, T. Pekarek, J. Brus, J. Czernek, P. Mokry, O. Humpa, M. Oravec, J. Jampilek,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 1997
Free Medical Journals
od 1997
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 1997-01-01
Open Access Digital Library
od 1997-01-01
Medline Complete (EBSCOhost)
od 2009-03-01
Health & Medicine (ProQuest)
od 1997-01-01
- MeSH
- antihypertenziva chemická syntéza chemie MeSH
- benzoáty chemická syntéza chemie MeSH
- magnetická rezonanční spektroskopie MeSH
- molekulární konformace MeSH
- molekulární modely MeSH
- piperaziny chemie MeSH
- soli chemie MeSH
- spektroskopie infračervená s Fourierovou transformací MeSH
- Publikační typ
- časopisecké články MeSH
Five new 3-(4-arylpiperazin-1-yl)-2-hydroxypropyl 4-propoxybenzoates were designed and synthesized as potential dual antihypertensive agents. The compounds were prepared as free bases and subsequently transformed to hydrochloride salts. The position of protonation of nitrogen atoms in the piperazine ring of hydrochloride salts was determined by means of (13)C-CP/MAS and (15)N-CP/MAS NMR and IR spectroscopy. Using these solid-state analytical techniques, it was found that both nitrogen atoms were protonated when excess hydrogen chloride was used for preparation of salts. On the other hand, when the equimolar amount of hydrogen chloride was used, piperazine nitrogen substituted by aryl was protonated.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17023935
- 003
- CZ-PrNML
- 005
- 20170720124200.0
- 007
- ta
- 008
- 170720s2016 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/molecules21060707 $2 doi
- 035 __
- $a (PubMed)27258242
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Marvanova, Pavlina $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 61242 Brno, Czech Republic. marvanovap@gmail.com.
- 245 10
- $a Synthesis and Characterization of New 3-(4-Arylpiperazin-1-yl)-2-hydroxypropyl 4-Propoxybenzoates and Their Hydrochloride Salts / $c P. Marvanova, T. Padrtova, T. Pekarek, J. Brus, J. Czernek, P. Mokry, O. Humpa, M. Oravec, J. Jampilek,
- 520 9_
- $a Five new 3-(4-arylpiperazin-1-yl)-2-hydroxypropyl 4-propoxybenzoates were designed and synthesized as potential dual antihypertensive agents. The compounds were prepared as free bases and subsequently transformed to hydrochloride salts. The position of protonation of nitrogen atoms in the piperazine ring of hydrochloride salts was determined by means of (13)C-CP/MAS and (15)N-CP/MAS NMR and IR spectroscopy. Using these solid-state analytical techniques, it was found that both nitrogen atoms were protonated when excess hydrogen chloride was used for preparation of salts. On the other hand, when the equimolar amount of hydrogen chloride was used, piperazine nitrogen substituted by aryl was protonated.
- 650 _2
- $a antihypertenziva $x chemická syntéza $x chemie $7 D000959
- 650 _2
- $a benzoáty $x chemická syntéza $x chemie $7 D001565
- 650 _2
- $a magnetická rezonanční spektroskopie $7 D009682
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a molekulární konformace $7 D008968
- 650 _2
- $a piperaziny $x chemie $7 D010879
- 650 _2
- $a soli $x chemie $7 D012492
- 650 _2
- $a spektroskopie infračervená s Fourierovou transformací $7 D017550
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Padrtova, Tereza $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 61242 Brno, Czech Republic. padrtova.tereza@seznam.cz.
- 700 1_
- $a Pekarek, Tomas $u Zentiva k.s., U kabelovny 130, 10237 Prague 10, Czech Republic. tomas.pekarek@atlas.cz.
- 700 1_
- $a Brus, Jiri $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky sq. 2, 16206 Prague 6, Czech Republic. brusjiri@seznam.cz.
- 700 1_
- $a Czernek, Jiri $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky sq. 2, 16206 Prague 6, Czech Republic. czernek@imc.cas.cz.
- 700 1_
- $a Mokry, Petr $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 61242 Brno, Czech Republic. mokryp@vfu.cz.
- 700 1_
- $a Humpa, Otakar $u CEITEC-Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic. otakar.humpa@ceitec.muni.cz.
- 700 1_
- $a Oravec, Michal $u Global Change Research Institute CAS, Belidla 986/4a, 60300 Brno, Czech Republic. oravec.m@czechglobe.cz.
- 700 1_
- $a Jampilek, Josef $u Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Odbojarov 10, 83232 Bratislava, Slovakia. josef.jampilek@gmail.com.
- 773 0_
- $w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 21, č. 6 (2016)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27258242 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20170720124653 $b ABA008
- 999 __
- $a ok $b bmc $g 1239616 $s 984848
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 21 $c 6 $e 20160601 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
- LZP __
- $a Pubmed-20170720